Protagonist Therapeutics Vs. Cytokinetics Industry Stock Comparison

Buy

56

PTGX
Protagonist Therapeutics

Last Price:

33.37

Seasonality Move:

14.81%

Buy

55

CYTK
Cytokinetics

Last Price:

53.96

Seasonality Move:

7.55%

Buy

56

Protagonist Therapeutics (PTGX) is a Buy

Is Protagonist Therapeutics a Buy, Sell or Hold?

The current Protagonist Therapeutics [PTGX] share price is $33.39. The Score for PTGX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
PTGX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Buy

55

Cytokinetics (CYTK) is a Buy

Is Cytokinetics a Buy, Sell or Hold?

The current Cytokinetics [CYTK] share price is $53.93. The Score for CYTK is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
CYTK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

PTGX Stock Price Chart

What is Protagonist Therapeutics's stock price today?

The Protagonist Therapeutics share price today is $33.39
The current trend is moderately bullish and PTGX is experiencing slight selling pressure.

CYTK Stock Price Chart

What is Cytokinetics's stock price today?

The Cytokinetics share price today is $53.93
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing buying pressure, which is a positive indicator for future bullish movement.

PTGX Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	1.48	Buy
Relative Strength Index (14 RSI):	60.08	Buy
Chaikin Money Flow:	-119501	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(29.07 - 33.45)	Buy
Bollinger Bands (100):	(26 - 31.02)	Buy

CYTK Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-2.04	Sell
Relative Strength Index (14 RSI):	46.58	Sell
Chaikin Money Flow:	781761	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(49.51 - 58.99)	Sell
Bollinger Bands (100):	(57.71 - 76.51)	Sell

PTGX Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	33.96	Sell
20-day SMA:	31.55	Buy
50-day SMA:	28.85	Buy
200-day SMA:	23.59	Buy
8-day EMA:	33.27	Buy
20-day EMA:	31.77	Buy
50-day EMA:	29.87	Buy
200-day EMA:	25.42	Buy

CYTK Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	53.47	Buy
20-day SMA:	52.83	Buy
50-day SMA:	60.85	Sell
200-day SMA:	55.3	Sell
8-day EMA:	53.07	Buy
20-day EMA:	54.08	Sell
50-day EMA:	58.8	Sell
200-day EMA:	57.11	Sell

Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates

Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $2.69 per share, an increase this year of $4.32 per share, and a decrease next year of $2.45 per share.

Cytokinetics Earnings Growth & CYTK Earnings Dates

Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.01 per share, an increase this year of $0.60 per share, and an increase next year of $0.05 per share.

Protagonist Therapeutics Technical Analysis

	Jun 3	Jun 4	Jun 5	Jun 6	Jun 7	Jun 10	Jun 11	Jun 12	Jun 13	Jun 14
	Jun
	03	04	05	06	07	10	11	12	13	14
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cytokinetics Technical Analysis

	Jun 3	Jun 4	Jun 5	Jun 6	Jun 7	Jun 10	Jun 11	Jun 12	Jun 13	Jun 14
	Jun
	03	04	05	06	07	10	11	12	13	14
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):